Success Rate of Radioactive Iodine Ablation in Low-Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients
Keywords:
Well-differentiated thyroid cancer, low risk of recurrence, radioactive iodine ablationAbstract
Objective: To evaluate success rate and factors affecting the success of radioactive iodine (RAI) ablation in low-risk of recurrence well-differentiated thyroid carcinoma patients.
Methods: Retrospective review of medical records was done in 132 low-risk of recurrence well-differentiated thyroid cancer (WDTC) patients between January 2007 and December 2013. All patients underwent 1) total thyroidectomy or equal surgery and 2) pre-ablative evaluationwith 99mTc-pertechnetate thyroid scan and 24-hour 131I thyroid uptake. RAIablation using low activity (30 mCi: n = 17) or high activity (80 or 100 mCi: n = 115) were given. Success rate of each activity and a comparison of success rates between 2 doses were analyzed. Criteria of successful ablation were composed of 1) no palpable neck mass 2) no demonstrable thyroid and tumor uptake on the follow up 6-12 months diagnostic whole body scan (WBS) and 3) stimulated thyroglobulin (Tg) lower than 2 ng/mL in the absence of interfering thyroglobulin antibodies (TgAb <40 IU/mL). Factors that may affect success of radioactive iodine ablation were studied; age, gender, tumor size, stage, pathological result, number of lesions, pre-ablation 24-hour 131I thyroid uptake, serum T4, TSH, Tg and TgAb at time of ablation.
Results: Overall success rate of RAI ablation was achieved in 95 patients out of 132 patients (72%). Low and high dose RAI ablation were completed in 9/17 patients (52.9%) and in 86/115 patients (74.8%), respectively (p-value = 0.082). Baseline Tg at time of ablation was a factor related to the success of ablation. Median Tg in success and failure group was 2.61 and 7.18 ng/mL, respectively (p = 0.023).
Conclusion: Success of 131I ablation in low-risk of recurrence well-differentiated thyroid cancer patients was 72%. The factor relating to ablative success was Tg level at time of ablation.
Downloads
Published
How to Cite
Issue
Section
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.